Blog
RSS FeedPosted by Michael Wonder on 15 Jun 2020
Teen with spinal muscular atrophy campaigns for wonder drug to survive
15 June 2020 - Taylor Fincham is one of 35 Kiwi children who suffer from spinal muscular atrophy. ...
Posted by Michael Wonder on 10 Jun 2020
Hawke's Bay mum's heartbreak as PHARMAC refuses spinal muscular atrophy drug for her two kids
9 June 2020 - Skylah-Rose Shaw 8 and her brother Zayden Shaw 10 suffer from spinal muscular atrophy a disease that ...
Posted by Michael Wonder on 09 Jun 2020
Lamotrigine concerns not addressed
8 June 2020 - A Dunedin mother whose son died soon after his usual epilepsy drug was replaced by a ...
Posted by Michael Wonder on 08 Jun 2020
PHARMAC switching anti-depressants too frequently - advocates
8 June 2020 - People who rely on consistent supply of medication are concerned about a planned brand switch of ...
Posted by Michael Wonder on 07 Jun 2020
Kiwis affected by epilepsy drug switch feel let down by PHARMAC review
6 June 2020 - A woman whose son died of a seizure after his epilepsy medication was switched says findings ...
Posted by Michael Wonder on 05 Jun 2020
Independent review of lamotrigine sole supply decision by PHARMAC
5 June 2020 - The review was published on the PHARMAC website today and shared with people who had been ...
Posted by Michael Wonder on 31 May 2020
New Zealand Pharmaceutical Schedule - 1 June 2020
1 June 2020 - The June 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 May 2020
Medicines New Zealand consulting on a new generation medicines policy
26 May 2020 - The New Zealand Institute of Economic Research have produced a discussion paper for Medicines New Zealand ...
Posted by Michael Wonder on 25 May 2020
Contraceptive pill rationed amid countrywide shortage
24 May 2020 - Hansi Bennett knows what it's like to feel constant pain. ...
Posted by Michael Wonder on 20 May 2020
Atomoxetine – further delay in change of funded brand and open access
20 May 2020 - PHARMAC is advising all interested parties that there is a further one-month delay in the listing ...
Posted by Michael Wonder on 14 May 2020
OIA response: effect of COVID-19 on medicine supply
14 May 2020 - PHARMAC responds to OIA request by releasing a raft of documents. ...
Posted by Michael Wonder on 12 May 2020
Racing getting more from budget than PHARMAC
12 May 2020 - It is a damning indictment of the Government’s priorities that the racing industry is getting more ...
Posted by Michael Wonder on 12 May 2020
Decision to fund pancreatic enzymes modified-release granules (Creon Micro)
12 May 2020 - PHARMAC is pleased to announce a decision to fund pancreatic enzymes modified-release granules (Creon Micro) from ...
Posted by Michael Wonder on 11 May 2020
PHARMAC funding increase "extremely disappointing"
11 May 2020 - Rare Disorders NZ is extremely disappointed with the announcement yesterday of a pre-budget boost to PHARMAC’s funding ...
Posted by Michael Wonder on 11 May 2020
Lung cancer victims miss out in drug funding boost - advocates
11 May 2020 - Advocates for lung cancer sufferers say the extra funding for PHARMAC in this year's Budget won't help ...